348 related articles for article (PubMed ID: 11345282)
1. Dose-ranging study of mometasone furoate dry powder inhaler in the treatment of moderate persistent asthma using fluticasone propionate as an active comparator.
O'Connor B; Bonnaud G; Haahtela T; Luna JM; Querfurt H; Wegener T; Lutsky BN
Ann Allergy Asthma Immunol; 2001 Apr; 86(4):397-404. PubMed ID: 11345282
[TBL] [Abstract][Full Text] [Related]
2. Mometasone furoate: efficacy and safety in moderate asthma compared with beclomethasone dipropionate.
Nathan RA; Nayak AS; Graft DF; Lawrence M; Picone FJ; Ahmed T; Wolfe J; Vanderwalker ML; Nolop KB; Harrison JE
Ann Allergy Asthma Immunol; 2001 Feb; 86(2):203-10. PubMed ID: 11258691
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of mometasone furoate dry powder inhaler vs fluticasone propionate metered-dose inhaler in asthma subjects previously using fluticasone propionate.
Wardlaw A; Larivee P; Eller J; Cockcroft DW; Ghaly L; Harris AG
Ann Allergy Asthma Immunol; 2004 Jul; 93(1):49-55. PubMed ID: 15281471
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of mometasone furoate administered once-daily in the evening in patients with persistent asthma dependent on inhaled corticosteroids.
D'Urzo A; Karpel JP; Busse WW; Boulet LP; Monahan ME; Lutsky B; Staudinger H
Curr Med Res Opin; 2005 Aug; 21(8):1281-9. PubMed ID: 16083538
[TBL] [Abstract][Full Text] [Related]
5. Comparison of once-daily to twice-daily treatment with mometasone furoate dry powder inhaler.
Noonan M; Karpel JP; Bensch GW; Ramsdell JW; Webb DR; Nolop KB; Lutsky BN
Ann Allergy Asthma Immunol; 2001 Jan; 86(1):36-43. PubMed ID: 11206236
[TBL] [Abstract][Full Text] [Related]
6. Comparison of once-daily mometasone furoate versus once-daily budesonide in patients with moderate persistent asthma.
Corren J; Berkowitz R; Murray JJ; Prenner B
Int J Clin Pract; 2003 Sep; 57(7):567-72. PubMed ID: 14529054
[TBL] [Abstract][Full Text] [Related]
7. Mometasone furoate administered once daily is as effective as twice-daily administration for treatment of mild-to-moderate persistent asthma.
Kemp JP; Berkowitz RB; Miller SD; Murray JJ; Nolop K; Harrison JE
J Allergy Clin Immunol; 2000 Sep; 106(3):485-92. PubMed ID: 10984368
[TBL] [Abstract][Full Text] [Related]
8. Once-daily mometasone furoate dry powder inhaler in the treatment of patients with persistent asthma.
Nayak AS; Banov C; Corren J; Feinstein BK; Floreani A; Friedman BF; Goldsobel A; Gottschlich GM; Hannaway PJ; Lampl KL; Lapidus RJ; Lawrence M; Lumry W; Munk Z; Pearlman D; Scardella AT; Schenkel EJ; Segal AT; Segall N; Silverman B; Shneyer L; Nolop KB; Harrison JE
Ann Allergy Asthma Immunol; 2000 Apr; 84(4):417-24. PubMed ID: 10795650
[TBL] [Abstract][Full Text] [Related]
9. Once-daily evening administration of mometasone furoate in asthma treatment initiation.
Bensch GW; Prenner B; Berkowitz R; Galant S; Ramsdell J; Lutsky B
Ann Allergy Asthma Immunol; 2006 Apr; 96(4):533-40. PubMed ID: 16680923
[TBL] [Abstract][Full Text] [Related]
10. Effects of treatment with mometasone furoate dry powder inhaler in children with persistent asthma.
Berger WE; Milgrom H; Chervinsky P; Noonan M; Weinstein SF; Lutsky BN; Staudinger H
Ann Allergy Asthma Immunol; 2006 Nov; 97(5):672-80. PubMed ID: 17165278
[TBL] [Abstract][Full Text] [Related]
11. Effects of mometasone furoate given once daily in the evening on lung function and symptom control in persistent asthma.
Karpel JP; Busse WW; Noonan MJ; Monahan ME; Lutsky B; Staudinger H
Ann Pharmacother; 2005 Dec; 39(12):1977-83. PubMed ID: 16264062
[TBL] [Abstract][Full Text] [Related]
12. Comparison of mometasone furoate dry powder inhaler and fluticasone propionate dry powder inhaler in patients with moderate to severe persistent asthma requiring high-dose inhaled corticosteroid therapy: findings from a noninferiority trial.
Harnest U; Price D; Howes T; Sussman G
J Asthma; 2008 Apr; 45(3):215-20. PubMed ID: 18415829
[TBL] [Abstract][Full Text] [Related]
13. Diskus and diskhaler: efficacy and safety of fluticasone propionate via two dry powder inhalers in subjects with mild-to-moderate persistent asthma.
Galant SP; van Bavel J; Finn A; Gross G; Pleskow W; Brown A; Hamedani AG; Harding SM
Ann Allergy Asthma Immunol; 1999 Mar; 82(3):273-80. PubMed ID: 10094218
[TBL] [Abstract][Full Text] [Related]
14. Mometasone furoate antagonizes AMP-induced bronchoconstriction in patients with mild asthma.
Holgate ST; Arshad H; Stryszak P; Harrison JE
J Allergy Clin Immunol; 2000 May; 105(5):906-11. PubMed ID: 10808170
[TBL] [Abstract][Full Text] [Related]
15. Comparable morning versus evening administration of once-daily mometasone furoate dry powder inhaler.
Zetterström O; Dahl R; Lindqvist A; Olsson P
Respir Med; 2008 Oct; 102(10):1406-11. PubMed ID: 18640826
[TBL] [Abstract][Full Text] [Related]
16. A study on the clinical equivalence and patient preference of fluticasone propionate 250 microg twice daily via the Diskus/Accuhaler inhaler or the Diskhaler inhaler in adult asthmatic patients.
Pieters WR; Stallaert RA; Prins J; Greefhorst AP; Bosman HG; van Uffelen R; Schreurs AJ; van Helmond JL; Janssen PG
J Asthma; 1998; 35(4):337-45. PubMed ID: 9669827
[TBL] [Abstract][Full Text] [Related]
17. A 12-week, multicenter, randomized, partially blinded, active-controlled, parallel-group study of budesonide inhalation suspension in adolescents and adults with moderate to severe persistent asthma previously receiving inhaled corticosteroids with a metered-dose or dry powder inhaler.
Murphy K; Noonan M; Silkoff PE; Uryniak T
Clin Ther; 2007 Jun; 29(6):1013-26. PubMed ID: 17692718
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of dry powder fluticasone propionate in children with persistent asthma.
LaForce CF; Pearlman DS; Ruff ME; Silvers WS; Weinstein SW; Clements DS; Brown A; Duke S; Harding SM; House KW
Ann Allergy Asthma Immunol; 2000 Nov; 85(5):407-15. PubMed ID: 11101186
[TBL] [Abstract][Full Text] [Related]
19. A 12-week dose-ranging study of fluticasone propionate powder in the treatment of asthma.
Wasserman SI; Gross GN; Schoenwetter WF; Munk ZM; Kral KM; Schaberg A; Kellerman DJ
J Asthma; 1996; 33(4):265-74. PubMed ID: 8707781
[TBL] [Abstract][Full Text] [Related]
20. Fluticasone propionate/salmeterol combination provides more effective asthma control than low-dose inhaled corticosteroid plus montelukast.
Nelson HS; Busse WW; Kerwin E; Church N; Emmett A; Rickard K; Knobil K
J Allergy Clin Immunol; 2000 Dec; 106(6):1088-95. PubMed ID: 11112891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]